LYNTRIAXONE I.M (Ceftriaxone Injection) 1g

LYNTRIAXONE I.M (Ceftriaxone Injection) 1g
Generic Name: Ceftriaxone.
Brand Names: Lyntriaxone
Class: Third-generation cephalosporins.
Strength: 1 g (per vial).
Form: Injectable powder for injection.
Amount: ₦‎2,400.

Description: Lyntriaxone I.M. 1g Injection is a high-potency, broad-spectrum antibiotic designed for intramuscular administration. It is used to treat a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and sexually transmitted diseases such as gonorrhoea. This product is supplied as a 1g vial of Ceftriaxone powder, intended for reconstitution with an appropriate diluent before injection. Please note that this package does not include sterile water or diluent and must be sourced separately.

Key Features:
• 1g Ceftriaxone powder for intramuscular injection
• Effective against a broad range of bacterial infections, including respiratory, skin, urinary tract, and sexually transmitted infections
• Intended for intramuscular (I.M.) administration
• Does not include sterile water or other diluent—must be reconstituted with an appropriate solvent before use
• Widely used in outpatient settings for its efficacy and ease of administration

Side Effects:
Common Side Effects:
• Injection Site Reactions: Pain, swelling, or tenderness (more common with I.M. use).
• Gastrointestinal Issues: Nausea, vomiting, diarrhoea.
• Allergic Reactions: Rash, itching, and in severe cases, anaphylaxis.
• Blood and Liver Function Changes: Altered blood cell counts, and elevated liver enzymes.
Severe (Rare) Side Effects:
• Severe Allergic Reactions: Seek immediate medical attention.
• Severe Skin Reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis.
• Hemolytic Anemia and Seizures (especially in renal impairment).

Cautions:
• Do not use antibiotics if you are allergic to cephalosporin.
• Caution in newborns with intravenous medicines containing calcium.
• Follow prescribed doses carefully, especially in children.
• Report any adverse reactions promptly to your healthcare provider.